Myriam Lorca

TL;DR: Since the introduction of current (and past) hydatid control campaigns, there have been clear technological improvements made in the diagnosis and treatment of human and animal cystic echinococcosis, the diagnosis of canine echinocentrosis, and the genetic characterisation of strains and vaccination against Echinococcus granulosus in animals.

TL;DR: It is concluded that individual antigens can be used to detect new IgG specificities present in the cord blood from infected newborns, and detection of IgMs and new fetal IgGs with recombinant antIGens may be use to sort out congenitally infected infants from uninfected ones, a method that might be applied to other infectious diseases.

TL;DR: An unbiased comparison of the same batch of six major E. granulosus antigens, namely, hydatid cyst fluid, native antigen B (AgB), two recombinant AgB subunits, an AgB-derived synthetic peptide, and recombinant cytosolic malate dehydrogenase, against the same serum collection is reported.

TL;DR: The rather low prevalence of toxoplasmosis in alpacas may be associated with their extensive management as well as the extreme climatic conditions of The Andes which apparently would not be favorable for the transmission of the parasite.

TL;DR: The high degree of significance obtained when the indirect IRMA and ELISA systems were compared, indicated that the relatively small sample number used was statistically satisfactory for the purposes of this investigation and the IRMA can be replaced by the ELISA, with advantages mainly derived from the cumbersome manipulation of radioactive wastes.